Clinical Hospital Center Osijek, University Josip Juraj Strosmayer Osijek, Osijek, Croatia.
Scand J Immunol. 2012 May;75(5):517-23. doi: 10.1111/j.1365-3083.2012.02681.x.
The aim of the study was to assess the frequency of SNP896A/G in the Toll-like receptor (TLR) 4 gene and SNP1350T/C in the TLR2 gene in patients with acute myocardial infarction (AMI) and to analyse the association of these SNPs with risk factors for atherosclerosis and clinical aspects of AMI in a sample of the Croatian population. We included 240 participants in the study: 120 AMI patients and 120 sex- and age-matched healthy blood donor controls. The SNP1350T/C variant in the TLR2 gene showed a lower frequency in the AMI patient group than in the control group (P = 0.033). The frequency of SNP896A/G variants in the TLR4 gene between the patients and the controls did not differ (P = 0.286). Significantly, fewer people had SNP1350T/C in the TLR2 gene (P = 0.003) among the participants with arterial hypertension than those without it. The frequency of SNP896A/G in TLR4 was the same in hypertensive patients compared with normotensive subjects (P = 0.088). SNP1350T/C in TLR2 was less frequent in the AMI patients and in those with hypertension. Thus, SNP1350T/C in TLR2 might play a protective role against AMI and arterial hypertension. The frequency of SNP896A/G in the TLR4 gene was not associated with AMI and arterial hypertension. Other risk factors for atherosclerosis and clinical aspects of myocardial infarction were not associated with the genotype distribution of the examined genes.
本研究旨在评估 Toll 样受体(TLR)4 基因中的 SNP896A/G 和 TLR2 基因中的 SNP1350T/C 在急性心肌梗死(AMI)患者中的频率,并分析这些 SNP 与动脉粥样硬化的危险因素和 AMI 的临床特征在克罗地亚人群样本中的关联。我们纳入了 240 名研究参与者:120 名 AMI 患者和 120 名性别和年龄匹配的健康献血者对照。TLR2 基因中的 SNP1350T/C 变异在 AMI 患者组中的频率低于对照组(P = 0.033)。TLR4 基因中 SNP896A/G 变异在患者和对照组之间的频率没有差异(P = 0.286)。重要的是,在患有高血压的参与者中,TLR2 基因中的 SNP1350T/C 频率明显低于没有高血压的参与者(P = 0.003)。与正常血压受试者相比,高血压患者 TLR4 基因中 SNP896A/G 的频率相同(P = 0.088)。TLR2 中的 SNP1350T/C 在 AMI 患者和高血压患者中较少见。因此,TLR2 中的 SNP1350T/C 可能对 AMI 和动脉高血压起保护作用。TLR4 基因中的 SNP896A/G 频率与 AMI 和动脉高血压无关。动脉粥样硬化的其他危险因素和心肌梗死的临床特征与所研究基因的基因型分布无关。